Mckesson Corporation (MCK)

$626.38

+1.38

(+0.22%)▲

Market is closed - opens 8 PM, 29 Nov 2024

Performance

  • $625.25
    $631.02
    $626.38
    downward going graph

    0.18%

    Downside

    Day's Volatility :0.91%

    Upside

    0.74%

    downward going graph
  • $431.35
    $637.51
    $626.38
    downward going graph

    31.14%

    Downside

    52 Weeks Volatility :32.34%

    Upside

    1.75%

    downward going graph

Returns

PeriodMckesson Corporation
3 Months
12.52%
6 Months
14.04%
1 Year
35.7%
3 Years
180.55%

Highlights

Market Capitalization
79.3B
Book Value
-$23.77
Dividend Share
2.57
Dividend Yield
0.45%
Earnings Per Share (EPS)
19.31
PE Ratio
32.37
PEG Ratio
1.29
Wall Street Target Price
641.325
Profit Margin
0.77%
Operating Margin TTM
0.8%
Return On Assets TTM
3.92%
Return On Equity TTM
0.0%
Revenue TTM
330.2B
Revenue Per Share TTM
2531.14
Quarterly Revenue Growth YOY
21.3%
Gross Profit TTM
12.4B
EBITDA
4.9B
Diluted Eps TTM
19.31
Quarterly Earnings Growth YOY
-0.62
EPS Estimate Current Year
27.59
EPS Estimate Next Year
31.02
EPS Estimate Current Quarter
6.88
EPS Estimate Next Quarter
8.33

Analyst Recommendation

Buy
    78%Buy
    21%Hold
    0
    0%Sell
Based on 23 Wall street analysts offering stock ratings for Mckesson Corporation(by analysts ranked 0 to 5 stars)
Based on 23 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
18
17
Hold
5
5
5
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 2.39%

Current $626.38
Target $641.33

Company Financials

FY19Y/Y Change
Revenue
214.3B
↑ 2.86%
Net Income
34.0M
↓ 49.25%
Net Profit Margin
0.02%
↓ 0.01%
FY20Y/Y Change
Revenue
231.1B
↑ 7.81%
Net Income
900.0M
↑ 2547.06%
Net Profit Margin
0.39%
↑ 0.37%
FY21Y/Y Change
Revenue
238.2B
↑ 3.11%
Net Income
-4.3B
↓ 582.11%
Net Profit Margin
-1.82%
↓ 2.21%
FY22Y/Y Change
Revenue
264.0B
↑ 10.8%
Net Income
1.1B
↓ 125.67%
Net Profit Margin
0.42%
↑ 2.24%
FY23Y/Y Change
Revenue
276.7B
↑ 4.83%
Net Income
3.6B
↑ 219.57%
Net Profit Margin
1.29%
↑ 0.87%
FY24Y/Y Change
Revenue
309.0B
↑ 11.65%
Net Income
3.0B
↓ 15.67%
Net Profit Margin
0.97%
↓ 0.32%
Q2 FY23Q/Q Change
Revenue
74.5B
↑ 8.09%
Net Income
958.0M
↑ 21.73%
Net Profit Margin
1.29%
↑ 0.15%
Q3 FY23Q/Q Change
Revenue
77.2B
↑ 3.67%
Net Income
664.0M
↓ 30.69%
Net Profit Margin
0.86%
↓ 0.43%
Q4 FY23Q/Q Change
Revenue
80.9B
↑ 4.77%
Net Income
589.0M
↓ 11.3%
Net Profit Margin
0.73%
↓ 0.13%
Q1 FY24Q/Q Change
Revenue
76.4B
↓ 5.62%
Net Income
791.0M
↑ 34.3%
Net Profit Margin
1.04%
↑ 0.31%
Q2 FY24Q/Q Change
Revenue
79.3B
↑ 3.83%
Net Income
915.0M
↑ 15.68%
Net Profit Margin
1.15%
↑ 0.11%
Q3 FY24Q/Q Change
Revenue
93.7B
↑ 18.12%
Net Income
241.0M
↓ 73.66%
Net Profit Margin
0.26%
↓ 0.89%
FY19Y/Y Change
Total Assets
59.7B
↓ 1.17%
Total Liabilities
50.0B
↑ 2.31%
FY20Y/Y Change
Total Assets
61.2B
↑ 2.64%
Total Liabilities
54.5B
↑ 9.09%
FY21Y/Y Change
Total Assets
65.0B
↑ 6.15%
Total Liabilities
63.6B
↑ 16.56%
FY22Y/Y Change
Total Assets
63.3B
↓ 2.64%
Total Liabilities
65.1B
↑ 2.39%
FY23Y/Y Change
Total Assets
62.3B
↓ 1.55%
Total Liabilities
63.8B
↓ 1.97%
FY24Y/Y Change
Total Assets
67.4B
↑ 8.22%
Total Liabilities
69.0B
↑ 8.2%
Q2 FY23Q/Q Change
Total Assets
64.1B
↑ 2.85%
Total Liabilities
65.3B
↑ 2.39%
Q3 FY23Q/Q Change
Total Assets
66.1B
↑ 3.11%
Total Liabilities
67.6B
↑ 3.4%
Q4 FY23Q/Q Change
Total Assets
66.5B
↑ 0.64%
Total Liabilities
68.2B
↑ 0.95%
Q1 FY24Q/Q Change
Total Assets
67.4B
↑ 1.4%
Total Liabilities
69.0B
↑ 1.24%
Q2 FY24Q/Q Change
Total Assets
71.7B
↑ 6.27%
Total Liabilities
73.1B
↑ 5.81%
Q3 FY24Q/Q Change
Total Assets
72.4B
↑ 1.06%
Total Liabilities
75.1B
↑ 2.77%
FY19Y/Y Change
Operating Cash Flow
4.0B
↓ 7.11%
Investing Cash Flow
-1.4B
↓ 9.26%
Financing Cash Flow
-2.2B
↓ 27.79%
FY20Y/Y Change
Operating Cash Flow
4.4B
↑ 8.37%
Investing Cash Flow
-579.0M
↓ 58.07%
Financing Cash Flow
-2.7B
↑ 22.77%
FY21Y/Y Change
Operating Cash Flow
4.5B
↑ 3.84%
Investing Cash Flow
-415.0M
↓ 28.32%
Financing Cash Flow
-1.7B
↓ 38.08%
FY22Y/Y Change
Operating Cash Flow
4.4B
↓ 2.38%
Investing Cash Flow
-89.0M
↓ 78.55%
Financing Cash Flow
-6.3B
↑ 273.36%
FY23Y/Y Change
Operating Cash Flow
5.2B
↑ 16.35%
Investing Cash Flow
-542.0M
↑ 508.99%
Financing Cash Flow
-4.4B
↓ 30.9%
Q2 FY23Q/Q Change
Operating Cash Flow
-1.1B
↓ 131.64%
Investing Cash Flow
-149.0M
↓ 38.93%
Financing Cash Flow
-843.0M
↓ 29.16%
Q3 FY23Q/Q Change
Operating Cash Flow
965.0M
↓ 191.73%
Investing Cash Flow
-315.0M
↑ 111.41%
Financing Cash Flow
-909.0M
↑ 7.83%

Technicals Summary

Sell

Neutral

Buy

Mckesson Corporation is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

Institutional Holdings

  • Vanguard Group Inc

    9.49%

  • BlackRock Inc

    9.04%

  • State Street Corp

    4.68%

  • Morgan Stanley - Brokerage Accounts

    4.05%

  • Massachusetts Financial Services Company

    3.89%

  • JPMorgan Chase & Co

    3.54%

Corporate Announcements

  • Mckesson Corporation Dividends March,2024

    In the quarter ending March,2024. Mckesson Corporation has declared dividend of $0.62

    Read More

Company Information

mckesson corporation, currently ranked 11th on the fortune 500 list, is a healthcare services and information technology company dedicated to making the business of healthcare run better. we partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. mckesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. for more information, visit us at www.mckesson.com.

Organization
Mckesson Corporation
Employees
45000
CEO
Mr. Brian S. Tyler Ph.D.
Industry
Wholesale Trade

FAQs